Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-545-4 | CAS number: 108-05-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 003
- Report date:
- 2003
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- Vinyl acetate
- EC Number:
- 203-545-4
- EC Name:
- Vinyl acetate
- Cas Number:
- 108-05-4
- Molecular formula:
- C4H6O2
- IUPAC Name:
- ethenyl acetate
- Details on test material:
- - Name of test material (as cited in study report): vinylacetate
- Physical state: Colourless liquid
- Analytical purity: >99.95%
- Lot/batch No.: Ch 20012003
- Expiration date of the lot/batch: 7 February 2003
- Manufacturer: Wacker-Chemie GmbH, Johannes-Hess Str. 24, D - 84489 Burghausen, Germany
- Storage condition of test material: In the original container in freezer (-20°C±3°C), away from direct sunlight
- Stability: Stable under storage conditions
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- other: CBA/CaOlaHsd
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Netherlands, B.V. Postbus 6174, NL 5960 AD Horst, The Netherlands
- Age at study initiation: 9-13 weeks
- Weight: 16.4-21.4 g (at the beginning of the acclimatisation period)
- Housing: 5 per cage in Makrolon type-3 cages
- Diet: Pelleted standard Kliba 3433, batch #75/02 mouse maintenance diet ad libitum
- Water: Community tap water ad libitum
- Acclimation period: 1 week
ENVIRONMENTAL CONDITIONS
- Temperature: 22±3°C
- Humidity: 30-70%
- Air changes (per hr): 10-15
- Photoperiod: 12 hrs dark / 12 hrs light
IN-LIFE DATES: From: 29 January 2003 To: 5 February 2003
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 5 %, 10 %, 25 %, 50 % (w/v) of vinyl acetate
- No. of animals per dose:
- 5
- Details on study design:
- RANGE FINDING TESTS:
- To determine the highest non-irritant and technically applicable test item concentration, a non-GLP pretest was performed in 2 mice with concentrations of 10 %, 25 %, 50 % (w/v) in acetone:olive oil, 4:1 (v/v) and 100 % (undiluted). No irritation effects were observed in the concentrations applied.
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Each test group of mice was treated by topical (epidermal) application to the dorsal surface of each ear lobe (left and right) with different test item concentrations of 5 %, 10 %, 25 %, 50 % (w/v) in acetone:olive oil, 4:1 (v/v) and 100 % (undiluted). The application volume, 25 µL, was spread over the entire dorsal surface (0-8 mm) of each ear lobe once daily for three consecutive days. A further group of mice was treated with an equivalent volume of the relevant vehicle alone (control animals).
- The ear swelling (ear thickness) of both ears (left and right) of mice at application area was measured using calipers prior to the first application, daily 24 (± 2) hours after each dosing and prior to necropsy.
- Five days after the first topical application, all mice were administered with 250 µL of 79.4 µCi/mL 3HTdR (equal to 19.8 µCi 3HTdR) by intravenous injection via a tail vein.
- Approximately five hours after treatment with 3HTdR all mice were euthanized by intraperitoneal injection of VETANARCOL (Veterinaria AG, Zurich). Both ears (left and right) of mice at apical area were punched using a biopsy punch (Stietel, 0 8 mm). Both punches of each animal were pooled and immediately weighed using an analytical balance.
- The draining lymph nodes were rapidly excised and pooled for each individual animal (2 nodes per mouse). Single cell suspensions (phosphate buffered saline) of pooled lymph node cells were prepared by gentle mechanical disaggregation through stainless steel gauze (200 µm mesh size). After washing two times with phosphate buffered saline (approx. 10 mL) the lymph node cells were resuspended in 5% trichloroacetic acid (approx. 3 mL) and incubated at approximately +4°C for at least 18 hours for precipitation of macromolecules. The precipitates were then resuspended in 5% trichloroacetic acid (1 mL) and transferred to glass scintillation vials with 10 mL of 'Ultima Gold' scintillation liquid and thoroughly mixed.
- The level of 3HTdR incorporation was then measured on a ß-scintillation counter. Similarly, background 3HTdR levels were also measured in two 1 mL aliquots of 5% trichloroacetic acid. The ß-scintillation counter expresses 3HTdR incorporation as the number of radioactive disintegrations per minute (DPM).
OTHER:
- The sensitivity and reliability of the experimental technique employed was assessed by use of a substance which is known to have skin sensitization properties in CBA/CaOlaHsd mice. The validation/positive control study was performed with ALPHA-HEXYLCINNAMALDEHYDE in acetone:olive oil, 4:1 (v/v) using CBA/CaOlaHsd mice (RCC Study Number 846871) between 8-22 January 2003. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- The mean values and standard deviations of body weights, ear thickness, ears punches weights and DPM values were calculated.
Results and discussion
- Positive control results:
- Stimulation indices of 2.5, 3.7 and 9.7 were determined with alpha-hexylcinnamaldehyde at concentrations of 5 %, 10 % and 25 % (w/v) in acetone:olive oil, 4:1 (v/v). The test item alpha-hexylcinnamaldehyde was found to be a sensitizer and an EC3 value of 7.08% (w/v) was derived.
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Remarks on result:
- other: see Remark
- Remarks:
- Stimulation indices of 2.0, 2.4, 1.9, 1.7 and 1.3 were determined with vinyl acetate at 5%, 10%, 25%, 50% (w/v) in acetone:olive oil, 4:1 (v/v) and 100% (undiluted). A Stimulation index of 16.6 was determined with the positive control substance 25% (w/v) in acetone:olive oil, 4:1 (v/v).
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: see Remark
- Remarks:
- A significant difference of dpm/mouse was determined at concentration of 10% (w/v) comparing with the vehicle control group at p:=0.05 (Dunnett-test, two sides). A significant difference of dpm/mouse was determined between the positive control group and the vehicle control group at p:=0.05 (Dunnett-test, two sides).
- Key result
- Parameter:
- SI
- Value:
- 2
- Test group / Remarks:
- 5% (w/v)
- Key result
- Parameter:
- SI
- Value:
- 2.4
- Test group / Remarks:
- 10% (w/v)
- Key result
- Parameter:
- SI
- Value:
- 1.9
- Test group / Remarks:
- 25% (w/v)
- Key result
- Parameter:
- SI
- Value:
- 1.7
- Test group / Remarks:
- 50% (w/v)
- Key result
- Parameter:
- SI
- Value:
- 1.3
- Test group / Remarks:
- 100%
Any other information on results incl. tables
No test item-related clinical signs were observed in any animals of the vehicle control group or Group 3 (5%). On the second application day a slight to moderate ear swelling was observed at both dosing sites in all mice of Group 2 (HCA, 25%) (moderate), Group 4 (10%) (slight, persisting for two days), Group 5 (25%) (slight), Group 6 (50%) (moderate) and Group 7 (100%, undiluted) (moderate), persisting for the remaining days. All treated animals survived the scheduled study period.
Summary of results
Group |
Test substance |
% (w/v) |
Dpm/Ln M±SD |
S.I. M±SD |
T value |
1 (-ve control) |
- |
- |
161±58 |
- |
- |
2 (+ve control) |
HCA |
25 |
2677±871 |
16.6±5.4 |
6.44** |
3 |
vinylacetate |
5 |
318±74 |
2.0±0.5 |
2.24 |
4 |
vinylacetate |
10 |
389±217 |
2.4±1.3 |
3.26** |
5 |
vinylacetate |
25 |
301±64 |
1.9±0.4 |
2.00 |
6 |
vinylacetate |
50 |
279±99 |
1.7±0.6 |
1.69 |
7 |
vinylacetate |
100 (undiluted) |
208±60 |
1.3±0.4 |
0.67 |
**significant difference at p 5 0.05 (two sides)
The results obtained and reported in the above table, show a negative dose response potential at the concentrations of 25%, 50% and 100% (undiluted), demonstrated by decreasing S.I. values. As some test item related findings such as, slight to moderate ear swelling were observed at the local dosing sites, it might be considered that the effect obtained is based on local irritation rather than on local Langerhans cells as the immuno targets.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Vinyl acetate was non-sensitising when tested up to 100% (undiluted) in the LLNA.
- Executive summary:
Five groups each of five female mice were treated with vinyl acetate at concentrations of 5%, 10%, 25%, 50% (w/v) in acetone:olive oil, 4:1 (v/v) and 100 % (undiluted) by topical application to the dorsum of each ear lobe (left and right) on three consecutive days. A negative control group of five mice was treated with an equivalent volume of the vehicle (acetone:olive oil, 4:1 (v/v)) only. A positive control group of five mice was treated with alpha-hexylcinnamaldehyde at concentration of 25% (w/v) in acetone:olive oil, 4:1 (v/v). The ear swelling (ear thickness) of both ears (left and right) of mice at application area were measured prior to the first application, daily 24 (± 2) hours after each dosing and prior to necropsy. Five days after the first topical application the mice were intravenously injected into a tail vein with radio-labelled thymidine (H-methyl thymidine). Approximately five hours after intravenous injection, the mice were sacrificed and both ears at apical area were punched and pooled per mouse. The pooled ear punches were immediately weighed. The draining auricular lymph nodes were excised and pooled per animal. Single cell suspensions of lymph node cells were prepared from pooled lymph nodes which were subsequently washed and incubated with trichloroacetic acid overnight. The proliferative capacity of pooled lymph node cells were determined by the incorporation of 3H-methyl thymidine measured in a R-scintillation counter. No test item-related clinical signs were observed in any animals of the vehicle control group or Group 3 (5%). On the second application day a slight to moderate ear swelling was observed at both dosing sites in all mice of Group 2 (HCA, 25%) (moderate), Group 4 (10%) (slight, persisting for two days), Group 5 (25%) (slight), Group 6 (50%) (moderate) and Group 7 (100%, undiluted) (moderate), persisting for the remaining days. All treated animals survived the scheduled study period.
Vinyl acetate (CAS 108-05-4) was found to be a non-sensitizer when tested up to 100% (undiluted).
Vinyl acetate showed a local irritation at 10%, 25%, 50% (w/v) in acetone:olive oil, 4:1 (v/v) and 100% (undiluted).
The positive control substance showed an allergenic potency when tested at concentration of 25% (w/v) in acetone:olive oil, 4:1 (v/v).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.